Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
1.
Mod Pathol ; 35(11): 1587-1595, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-35701667

RESUMEN

DEK::AFF2 carcinoma of the sinonasal tract is an emerging entity. The tumor is typically characterized by papillary proliferation of non-keratinizing squamous epithelial cells with monotonous cytologic features, which may mimic other sinonasal tumors. The confirmation of this gene fusion has thus far relied solely on next-generation sequencing, fluorescence in situ hybridization (FISH), or reverse transcription polymerase chain reaction (RT-PCR). This current study aimed to validate an immunohistochemical assay for AFF2 C-terminus as an ancillary marker. We first analyzed publicly available RNA sequencing data of sinonasal tumors from the national center for biotechnology information (NCBI) sequence read archive and identified 3 DEK::AFF2 carcinomas out of 28 sinonasal tumors. The gene expression of AFF2 was significantly higher in the fusion-positive cases compared to the wild-type tumors (p < 0.001), while DEK was not. We then optimized an immunohistochemical assay with an anti-AFF2 C-terminus antibody for ancillary diagnosis. Seventeen DEK::AFF2 carcinomas, including 11 cases with predominantly low-grade morphology and one showing glandular differentiation, as well as 78 DEK FISH-negative sinonasal tumors were evaluated by AFF2 immunohistochemistry (IHC). Sixteen of the 17 DEK::AFF2 carcinomas showed nuclear AFF2 expression in ≥30% of tumor cells, including one decalcified case that failed FISH and RT-PCR confirmation. The one case that was negative for AFF2 IHC in the tumor cells also lacked expression in the internal positive control. It was thus considered a failure of the IHC rather than a truly negative case and was excluded from the statistical analysis. All DEK FISH-negative sinonasal tumors were negative for nuclear AFF2 expression. The nuclear expression of AFF2 IHC showed 100% sensitivity and specificity for DEK::AFF2 carcinoma. Accordingly, AFF2 IHC is a highly sensitive and specific ancillary marker that distinguishes DEK-AFF2 carcinoma from the other sinonasal tumors with overlapping morphological features and may be an especially useful alternative for decalcified specimens.


Asunto(s)
Carcinoma , Senos Paranasales , Humanos , Hibridación Fluorescente in Situ , Biomarcadores de Tumor/genética , Biomarcadores de Tumor/análisis , Carcinoma/diagnóstico , Carcinoma/genética , Carcinoma/patología , Inmunohistoquímica , Senos Paranasales/química , Senos Paranasales/patología , Proteínas de Unión a Poli-ADP-Ribosa/genética , Proteínas Cromosómicas no Histona/genética , Proteínas Oncogénicas/genética , Proteínas Nucleares/genética
2.
Am J Surg Pathol ; 43(6): 747-754, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30829729

RESUMEN

Biphenotypic sinonasal sarcoma (BSNS) is a locally aggressive tumor occurring in the sinonasal region. It harbors both myogenic and neural differentiation and is characterized by PAX3 rearrangement with MAML3 as the most frequent fusion partner, but the partner of PAX3 remains unidentified in a subset of cases. About 70 cases have been reported so far. In this study, we report a series of 41 cases with clinical, pathologic, and molecular description. Twenty-five (61%) patients were female individuals, and the median age was 49 years. Tumors arose predominantly in the nasal cavity and ethmoidal sinuses. Local recurrences occurred in 8 cases of the 25 (32%). Histologic features were characteristic of BSNS, with 5 cases showing focal rhabdomyoblastic differentiation. Immunohistochemistry showed a constant positivity of S100 protein and PAX3 and negativity of SOX10. MyoD1 was focally positive in 91% of cases, whereas only 20% were positive for myogenin. Molecular analysis showed a PAX3-MAML3 transcript in 37 cases (90%). RNA sequencing was performed in the 4 negative cases for PAX3-MAML3 fusion, and it showed that 1 case harbored a PAX3-FOXO1 fusion, as previously described in the literature, and 2 novel fusions: PAX3-WWTR1 fusion in 2 cases and PAX3-NCOA2 fusion in 1 case. RNA sequencing results were confirmed by fluorescence in situ hybridization, reverse transcription-polymerase chain reaction, and Sanger sequencing. The PAX3-NCOA2-positive case showed focal rhabdomyoblastic differentiation. In conclusion, we report 2 novel fusions (PAX3-WWTR1 and PAX3-NCOA2) in BSNS and show that MyoD1 is more sensitive than myogenin for demonstrating myogenic differentiation in this tumor.


Asunto(s)
Biomarcadores de Tumor , Cavidad Nasal , Neoplasias de los Senos Paranasales , Senos Paranasales , Sarcoma , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/genética , Diferenciación Celular , Femenino , Fusión Génica , Predisposición Genética a la Enfermedad , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Masculino , Persona de Mediana Edad , Proteína MioD/análisis , Cavidad Nasal/química , Cavidad Nasal/patología , Coactivador 2 del Receptor Nuclear/genética , Proteínas de Fusión Oncogénica/genética , Factor de Transcripción PAX3/genética , Factores de Transcripción Paired Box/genética , Neoplasias de los Senos Paranasales/química , Neoplasias de los Senos Paranasales/genética , Neoplasias de los Senos Paranasales/patología , Neoplasias de los Senos Paranasales/terapia , Senos Paranasales/química , Senos Paranasales/patología , Fenotipo , Estudios Prospectivos , Estudios Retrospectivos , Sarcoma/química , Sarcoma/genética , Sarcoma/patología , Sarcoma/terapia , Transactivadores/genética , Proteínas Coactivadoras Transcripcionales con Motivo de Unión a PDZ
3.
Ann Allergy Asthma Immunol ; 119(4): 310-316.e2, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28870448

RESUMEN

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the upper airway and is tightly linked with airway hyperresponsiveness (AHR) and asthma. However, the surrogate biomarkers for indicating AHR and asthma in patients with CRSwNP remain elusive. OBJECTIVE: To investigate the surrogate biomarkers for indicating AHR and asthma in patients with CRSwNP. METHODS: In this study, sinonasal tissues were collected from 42 patients with CRSwNP (asthma, n = 17; asymptomatic AHR, n = 11; non-AHR, n = 14), 11 patients with chronic rhinosinusitis without nasal polyps (CRSsNP), and 13 controls. The protein and messenger RNA levels of interleukin (IL) 25 and other cytokines in nasal polyp (NP) and control sinonasal tissues were determined by quantitative real-time polymerase chain reaction and multiplex immunoassay, respectively. Multivariate logistic regression and receiver operating characteristic curve analysis were performed to assess the clinical relevance of IL-25. RESULTS: We found that the protein and messenger RNA levels of IL-25 were significantly increased in NP tissues compared with the control sinonasal tissues from patients with CRSwNP, patients with CRSsNP, and controls. Multivariate logistic regression revealed that the nasal IL-25 protein level and nasal and blood eosinophil counts were independent risk factors for AHR in patients with CRSwNP. According to receiver operating characteristic curve analysis, nasal tissue IL-25 had a sensitivity of 91.4% and a specificity of 62.8% (area under the curve, 0.845) at the cutoff level of 5 pg/µL for indicating AHR in this CRSwNP cohort. CONCLUSION: Our findings indicated that IL-25 was significantly increased in NP tissues and may be considered as the molecular indicator for AHR in patients with CRSwNP. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02110654.


Asunto(s)
Asma/diagnóstico , Interleucina-17/genética , Pólipos Nasales/diagnóstico , Rinitis/diagnóstico , Sinusitis/diagnóstico , Adulto , Asma/complicaciones , Asma/genética , Asma/inmunología , Biomarcadores/metabolismo , Estudios de Casos y Controles , Enfermedad Crónica , Eosinófilos/inmunología , Eosinófilos/patología , Femenino , Expresión Génica , Humanos , Interleucina-17/inmunología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Pólipos Nasales/complicaciones , Pólipos Nasales/genética , Pólipos Nasales/inmunología , Senos Paranasales/química , Senos Paranasales/inmunología , Senos Paranasales/patología , Proyectos Piloto , ARN Mensajero/genética , ARN Mensajero/inmunología , Curva ROC , Rinitis/complicaciones , Rinitis/genética , Rinitis/inmunología , Sinusitis/complicaciones , Sinusitis/genética , Sinusitis/inmunología
4.
Am J Surg Pathol ; 41(4): 458-471, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28291122

RESUMEN

To more fully characterize the clinical and pathologic spectrum of a recently described tumor entity of the sinonasal tract characterized by loss of nuclear expression of SMARCB1 (INI1), we analyzed 39 SMARCB1-deficient sinonasal carcinomas collected from multiple medical centers. The tumors affected 23 males and 16 females with an age range of 19 to 89 years (median, 52). All patients presented with locally advanced disease (T3, n=5; T4, n=27) involving the sinuses (mainly ethmoid) with variable involvement of the nasal cavity. Thirty patients received surgery and/or radiochemotherapy with curative intent. At last follow-up, 56% of patients died of disease 0 to 102 months after diagnosis (median, 15), 2 were alive with disease, and 1 died of an unrelated cause. Only 9 patients (30%) were alive without disease at last follow-up (range, 11 to 115 mo; median, 26). The original diagnosis of retrospectively identified cases was most often sinonasal undifferentiated carcinoma (n=14) and nonkeratinizing/basaloid squamous cell carcinoma (n=5). Histologically, most tumors displayed either a predominantly basaloid (61%) or plasmacytoid/rhabdoid morphology (36%). The plasmacytoid/rhabdoid form consisted of sheets of tumor cells with abundant, eccentrically placed eosinophilic cytoplasm, whereas similar cells were typically rare and singly distributed in the basaloid variant. Glandular differentiation was seen in a few tumors. None of the cases showed squamous differentiation or surface dysplasia. By immunohistochemistry, the tumors were positive for pancytokeratin (97%), CK5 (64%), p63 (55%), and CK7 (48%); and they were negative for NUT (0%). Epstein-Barr virus and high-risk human papillomavirus was not detected by in situ hybridization. Immunohistochemical loss of SMARCB1 (INI1) expression was confirmed for all 39 tumors. Investigation of other proteins in the SWI/SNF complex revealed co-loss of SMARCA2 in 4 cases, but none were SMARCA4 deficient or ARID1A deficient. Of 27 tumors with SMARCB1 fluorescence in situ hybridization analysis, 14 showed homozygous (biallelic) deletions and 7 showed heterozygous (monoallelic) deletions. SMARCB1-deficient sinonasal carcinoma represents an emerging poorly differentiated/undifferentiated sinonasal carcinoma that (1) cannot be better classified as another specific tumor type, (2) has consistent histopathologic findings (albeit with some variability) with varying proportions of plasmacytoid/rhabdoid cells, and (3) demonstrates an aggressive clinical course. This entity should be considered in any difficult-to-classify sinonasal carcinoma, as correct diagnosis will be mandatory for optimizing therapy and for further delineation of this likely underdiagnosed disease.


Asunto(s)
Biomarcadores de Tumor/deficiencia , Carcinoma de Células Escamosas/química , Carcinoma/química , Neoplasias del Seno Maxilar/química , Neoplasias Nasales/química , Senos Paranasales/química , Proteína SMARCB1/deficiencia , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/genética , Biopsia , Carcinoma/genética , Carcinoma/patología , Carcinoma/terapia , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/terapia , Diferenciación Celular , Quimioradioterapia Adyuvante , Femenino , Alemania , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Imagen por Resonancia Magnética , Masculino , Neoplasias del Seno Maxilar/genética , Neoplasias del Seno Maxilar/patología , Neoplasias del Seno Maxilar/terapia , Persona de Mediana Edad , Procedimientos Quírurgicos Nasales , Estadificación de Neoplasias , Neoplasias Nasales/genética , Neoplasias Nasales/patología , Neoplasias Nasales/terapia , Senos Paranasales/patología , Reacción en Cadena de la Polimerasa , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Proteína SMARCB1/genética , Factores de Tiempo , Resultado del Tratamiento , Estados Unidos , Adulto Joven
5.
Am J Surg Pathol ; 41(4): 525-534, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28009611

RESUMEN

We present a series of nonectopic pituitary adenomas presenting as polypoid sinonasal or nasopharyngeal masses. Thirteen cases diagnosed by biopsies from the nasal cavity, sinuses, or nasopharynx were identified from a series of 1288 surgical pituitary specimens. The patients included 5 men and 8 women ranging from 29 to 69 years of age. The presentations included nasal obstruction (4 cases), headaches (3), visual defects (2), recurrent nose bleeds (1), rhinorrhea (1), sepsis (1), fatigue (1), and hyperthyroidism (1). All patients had large tumors involving the sella and extending inferiorly to involve the sphenoid sinus in 10 cases, ethmoid in 8, nasopharynx in 3, nasal cavity in 6, maxillary and frontal sinuses in 1 case each. In 3 patients, the biopsy was from the nasopharynx, in 4 from the nasal cavity, in 4 from the sphenoid sinus, and in 2 from the ethmoid sinus. The correct diagnosis of pituitary adenoma was initially made in 10 cases. In 3 cases the initial diagnosis was incorrect; 2 tumors were classified as olfactory neuroblastoma, one of those was reclassified as neuroendocrine carcinoma, and 1 case was initially diagnosed as neuroendocrine carcinoma with aberrant adrenocorticotrophic hormone expression. Clinical follow-up (2 to 25 y) and treatment information was available in 10 cases. All 10 patients were alive, either free of disease (4 cases) or with disease (6 cases). In 2 cases, the wrong diagnoses led to incorrect treatment with significant morbidity. These cases illustrate that pituitary adenomas can invade nasopharynx and sinonasal cavities and when they do, they present a possible diagnostic pitfall with potentially serious consequences. We demonstrate the need to always consider this entity when encountering a nasopharyngeal or sinonasal tumor with neuroendocrine features.


Asunto(s)
Adenoma/patología , Neoplasias Nasofaríngeas/patología , Nasofaringe/patología , Neoplasias Nasales/patología , Senos Paranasales/patología , Neoplasias Hipofisarias/patología , Adenoma/química , Adenoma/terapia , Adulto , Anciano , Biomarcadores de Tumor/análisis , Biopsia , Errores Diagnósticos , Supervivencia sin Enfermedad , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Nasofaringe/química , Invasividad Neoplásica , Senos Paranasales/química , Neoplasias Hipofisarias/química , Neoplasias Hipofisarias/terapia , Valor Predictivo de las Pruebas , Factores de Tiempo , Resultado del Tratamiento
6.
Vojnosanit Pregl ; 72(10): 937-41, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26665562

RESUMEN

INTRODUCTION: Primary mucosal melanoma of the sinonasal tract is a rare neoplasm, accounting for less than 1% of all melanomas. It has an aggressive and unpredictable biologic behavior characterized by frequent incidence of local recurrence, local and distant metastasis of the disease. CASE REPORT: This report summarizes the results of the previous research concerning sinonasal mucosal melanoma, and by the example of the two patients suffering from mucosal melanoma, we described clinical and histopathological features of this rare neoplasm and our experience in its diagnosis and treatment. CONCLUSION: Only histopathological analysis complemented by immunobistochemical analysis contributes to early and accurate diagnosis of the disease.


Asunto(s)
Melanoma/patología , Mucosa Nasal/patología , Neoplasias de los Senos Paranasales/patología , Senos Paranasales/patología , Anciano , Anciano de 80 o más Años , Antineoplásicos/uso terapéutico , Biomarcadores de Tumor/análisis , Biopsia , Femenino , Humanos , Inmunohistoquímica , Masculino , Melanoma/química , Melanoma/terapia , Mucosa Nasal/química , Mucosa Nasal/efectos de los fármacos , Mucosa Nasal/cirugía , Cuidados Paliativos , Neoplasias de los Senos Paranasales/química , Neoplasias de los Senos Paranasales/terapia , Senos Paranasales/química , Senos Paranasales/efectos de los fármacos , Senos Paranasales/cirugía , Radioterapia Adyuvante , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
7.
Rhinology ; 52(4): 366-70, 2014 12.
Artículo en Inglés | MEDLINE | ID: mdl-25479216

RESUMEN

BACKGROUND: Inverted papilloma (IP) is a benign lesion of the nasal cavity and paranasal sinuses. The aetiology of IP remains unclear. OBJECTIVE: To assess whether the sinonasal bacteriology of patients with IP is different from the bacteriology of chronic rhinosinusitis (CRS) patients and if there are differences between primary and recurrent IP. METHODOLOGY: A retrospective review of patients with IP at a tertiary referral centre. Intraoperative microbiology results from primary and revision IP resections were compared to each other and to published microbiology data from CRS patients. RESULTS: Twenty-six cases of IP were identified with a total of 83 intraoperative cultures, of which 43 were positive. The most common isolates were coagulase negative Staphylococcus (SCN), Propionibacterium, Staphylococcus aureus, and Streptococcus. The trends in the prevalence of isolates were similar to those reported for CRS patients. Additionally, similar bacteriology was identified between primary and revision IP patients. CONCLUSION: In our series, the most common bacterial isolates found in IP are similar to those of CRS, as is the prevalence of gram-negative organisms. Additionally, we did not demonstrate a difference between primary and recurrent IP. Our findings suggest that IP does not result from specific sinonasal microbial exposure.


Asunto(s)
Cavidad Nasal/fisiología , Papiloma Invertido/cirugía , Senos Paranasales/patología , Sinusitis/microbiología , Staphylococcus aureus/aislamiento & purificación , Bacteriología , Humanos , Senos Paranasales/química , Estudios Retrospectivos , Staphylococcus aureus/química
8.
Am J Surg Pathol ; 38(9): 1282-9, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25007146

RESUMEN

SMARCB1 (INI-1) is a tumor-suppressor gene located on chromosome 22q11.2. Its gene product is ubiquitously expressed in nuclei of all normal tissues. SMARCB1 gene inactivation has been implicated in the pathogenesis of a diverse group of malignant neoplasms that tend to share "rhabdoid" cytomorphology. This group of SMARCB1-deficient tumors is now further expanded by a subset of carcinomas arising in the sinonasal tract. SMARCB1 immunostaining was performed on 142 sinonasal carcinomas. Tumors that showed loss of expression were further characterized for SMARCB1 deletions by fluorescence in situ hybridization. Nine of 142 (6%) primary sinonasal carcinomas showed loss of SMARCB1 expression by immunohistochemistry. Five patients were women, and patients ranged in age from 33 to 78 years (mean 59 y). The SMARCB1-deficient tumors were characterized by nests, sheets, and cords of cells without any histologic evidence of specific (eg, squamous or glandular) differentiation. The tumors comprised varying proportions of basaloid and rhabdoid cells. The SMARCB1-deficient carcinomas had been diagnosed as nonkeratinizing squamous cell carcinomas (n=3), sinonasal undifferentiated carcinomas (n=2), myoepithelial carcinoma (n=2), nonintestinal adenocarcinoma (n=1), and carcinoma, not otherwise specified (n=1). Fluorescence in situ hybridization analysis revealed SMARCB1 deletions in 6 of 8 (75%) carcinomas. The SMARCB1-deficient carcinomas did not harbor human papillomavirus or NUT-1 alterations. Six patients presented with T4 disease, 5 patients developed local recurrences and/or distant metastases, and 4 died of their disease. Inactivation of the SMARCB1 tumor-suppressor gene appears to be involved in the pathogenesis of a subset of sinonasal carcinomas, further expanding the family of SMARCB1-deficient neoplasms and further delineating a bewildering group of poorly/undifferentiated, aggressive carcinomas arising at this site. The ability to detect SMARCB1 loss by immunohistochemistry, particularly when dealing with poorly differentiated carcinomas with basaloid or rhabdoid features, should facilitate a more comprehensive understanding of these sinonasal carcinomas including clinical behavior and response to targeted therapies.


Asunto(s)
Biomarcadores de Tumor/deficiencia , Carcinoma/química , Proteínas Cromosómicas no Histona/deficiencia , Proteínas de Unión al ADN/deficiencia , Neoplasias de los Senos Paranasales/química , Senos Paranasales/química , Factores de Transcripción/deficiencia , Adulto , Anciano , Biomarcadores de Tumor/genética , Biopsia , Carcinoma/genética , Carcinoma/mortalidad , Carcinoma/secundario , Carcinoma/terapia , Núcleo Celular/química , Proteínas Cromosómicas no Histona/genética , Proteínas de Unión al ADN/genética , Femenino , Eliminación de Gen , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Neoplasias de los Senos Paranasales/genética , Neoplasias de los Senos Paranasales/mortalidad , Neoplasias de los Senos Paranasales/patología , Neoplasias de los Senos Paranasales/terapia , Senos Paranasales/patología , Proteína SMARCB1 , Factores de Tiempo , Análisis de Matrices Tisulares , Factores de Transcripción/genética , Resultado del Tratamiento
9.
Am J Surg Pathol ; 38(9): 1274-81, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24832165

RESUMEN

Poorly differentiated sinonasal carcinomas are a heterogenous group of aggressive neoplasms that encompasses squamous cell carcinoma including basaloid variant, lymphoepithelial carcinoma, sinonasal undifferentiated carcinoma, and neuroendocrine-type small cell carcinoma. We herein describe 3 cases of a hitherto unreported variant combining features of basaloid carcinoma with variable intermingled rhabdoid cells. Patients were 2 women (aged 28 and 35) and a man (52 y) who presented with sinonasal masses. All had advanced local disease with bone involvement (pT4). None had a history of irradiation or a family history of rhabdoid tumors. Treatment was surgery and adjuvant chemoradiation. One patient developed liver, lung, pleural, and pericardial metastases (63 mo) and is currently (70 mo) alive under palliative treatment. Another developed recurrent cervical lymph node metastases and died of disease 8.5 years later. The youngest patient was disease-free at last follow-up 7 years later. Histologic features were very similar in all 3 cases and showed intimate admixture of compact basaloid cell nests with peripheral palisading, perivascular pseudorosettes, and a few scattered rhabdoid cells. Rhabdoid cells were more extensive in the metastasis in 1 case but formed a minor inconspicuous component in the primary tumors in all cases. Striking features common to all cases were (1) basaloid "blue" appearance at low power, (2) papilloma-like exophytic component, (3) extensive pagetoid surface growth with prominent denuding features, and (4) replacement of underlying mucous glands mimicking an inverted papilloma. Clear-cut origin from benign papilloma and overt squamous differentiation were lacking. Diffuse (2) or partial (1) p16 expression was noted, but all cases lacked human papillomavirus DNA by molecular tests. In situ hybridization was negative for Epstein-Barr virus. Immunohistochemistry showed diffuse expression of pancytokeratin. CK5 and vimentin showed intermingling of CK5/vimentin basaloid and CK5/vimentin rhabdoid cells. Complete loss of nuclear SMARCB1 expression was seen in all cases including also the denuding carcinoma in situ-like surface lesions. To our knowledge, this variant of sinonasal carcinoma has not been reported before. The identical features in all 3 cases suggest a specific disease rather than a nonspecific dedifferentiated phenotype. Awareness of this rare variant and thus reporting of additional cases is necessary for defining its full morphologic and biological spectrum.


Asunto(s)
Biomarcadores de Tumor/deficiencia , Carcinoma/química , Proteínas Cromosómicas no Histona/deficiencia , Proteínas de Unión al ADN/deficiencia , Neoplasias de los Senos Paranasales/química , Senos Paranasales/química , Factores de Transcripción/deficiencia , Adulto , Biopsia , Carcinoma/secundario , Carcinoma/terapia , Núcleo Celular/química , Resultado Fatal , Femenino , Humanos , Inmunohistoquímica , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Neoplasias de los Senos Paranasales/patología , Neoplasias de los Senos Paranasales/terapia , Senos Paranasales/patología , Valor Predictivo de las Pruebas , Proteína SMARCB1 , Factores de Tiempo , Resultado del Tratamiento
10.
Histol Histopathol ; 29(10): 1315-24, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24737387

RESUMEN

Secretory cells in the seromucous glands of paranasal sinuses secrete antibacterial proteins for innate immune mucosal integrity. We studied the localization of antimicrobial and cytoskeletal components of the human seromucous glands and respiratory epithelium of the maxillary sinus and the ethmoidal cells by immunohistochemical methods. The presence of a variety of defense proteins such as lysozyme, lactoferrin, cathelicidin, and defensin-1, -2, -3 point to a crucial role in the immune defense for the respiratory tract. Cytoskeletal proteins such as actin, myosin 2, cytokeratin 7 and 19, α- and ß-tubulin, investigated for the first time in glands of paranasal sinuses, showed a stronger expression at the apical and lateral cell membrane. The localization of the cytoskeletal proteins might point to their participation in exocrine secretory processes and stabilizing effects.


Asunto(s)
Antiinfecciosos/química , Proteínas del Citoesqueleto/química , Glándulas Exocrinas/química , Mucosa Nasal/química , Senos Paranasales/química , Adolescente , Adulto , Anciano , Antiinfecciosos/metabolismo , Glándulas Exocrinas/metabolismo , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Adulto Joven
11.
Int Forum Allergy Rhinol ; 3(4): 299-306, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23129253

RESUMEN

BACKGROUND: Ventilation of and gas exchange between the nose and the paranasal sinuses are believed to occur by convection and diffusion based on experiments that neglect the effects of physiological respiration and aerodynamic forces at the sinonasal interface (SNI). Based on these experiments, the exchange of gas is presumed to be slow, and principally dependent on gas concentration and diameter, number, and location of ostia. METHODS: In 12 healthy adult volunteers, real-time sinus nitric oxide measurements were obtained with catheters placed through natural ostia during respiratory maneuvers. RESULTS: The nose is a masterful collection of aerodynamic foils and channels designed to accomplish powered sinonasal gas exchange and ventilation within a few seconds during each inspiration. CONCLUSION: The new perspective on the functional anatomy of the SNI demands a paradigm shift that is followed by physiological, medical, and surgical implications and a radical change in our perception and understanding.


Asunto(s)
Senos Paranasales/anatomía & histología , Senos Paranasales/fisiología , Respiración , Adulto , Difusión , Femenino , Humanos , Masculino , Óxido Nítrico/análisis , Senos Paranasales/química , Intercambio Gaseoso Pulmonar/fisiología , Ventilación Pulmonar
12.
J Environ Public Health ; 2012: 312836, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22220187

RESUMEN

A family of five and pet dog who rented a water-damaged home and developed multiple health problems. The home was analyzed for species of mold and bacteria. The diagnostics included MRI for chronic sinusitis with ENT and sinus surgery, and neurological testing for neurocognitive deficits. Bulk samples from the home, tissue from the sinuses, urine, nasal secretions, placenta, umbilical cord, and breast milk were tested for the presence of trichothecenes, aflatoxins, and Ochratoxin A. The family had the following diagnosed conditions: chronic sinusitis, neurological deficits, coughing with wheeze, nose bleeds, and fatigue among other symptoms. An infant was born with a total body flare, developed multiple Cafe-au-Lait pigmented skin spots and diagnoses with NF1 at age 2. The mycotoxins were detected in bulk samples, urine and nasal secretions, breast milk, placenta, and umbilical cord. Pseudomonas aueroginosa, Acinetobacter, Penicillium, and Aspergillus fumigatus were cultured from nasal secretions (father and daughter). RT-PCR revealed A. fumigatus DNA in sinus tissues of the daughter. The dog had 72 skin lesions (sebaceous glands and lipomas) from which trichothecenes and ochratoxin A. were detected. The health of the family is discussed in relation to the most recent published literature regarding microbial contamination and toxic by-products present in water-damaged buildings.


Asunto(s)
Materiales de Construcción/microbiología , Exposición a Riesgos Ambientales/efectos adversos , Hongos/aislamiento & purificación , Micotoxinas/análisis , Sinusitis/etiología , Microbiología del Agua , Aflatoxinas/análisis , Animales , Manchas Café con Leche/epidemiología , Manchas Café con Leche/etiología , Manchas Café con Leche/patología , Preescolar , Perros , Contaminación Ambiental , Femenino , Hongos/metabolismo , Humanos , Lactante , Masculino , Ocratoxinas/análisis , Senos Paranasales/química , Senos Paranasales/microbiología , Senos Paranasales/cirugía , Embarazo , Complicaciones Infecciosas del Embarazo , Sinusitis/epidemiología , Sinusitis/microbiología
14.
Otolaryngol Head Neck Surg ; 144(2): 159-69, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21634057

RESUMEN

OBJECTIVE: To critically and systematically review the data available on the sinonasal application of nasal nitric oxide measurement, particularly its use as a diagnostic, prognostic, or treatment effect indicator. DATA SOURCES: EMBASE 1980 to February 10, 2010; Medline 1950 to February 10, 2010; Cochrane Collaboration database; NHS Evidence Health Information Resources database. Review Methods. The databases were searched using a search strategy designed to include manuscripts relevant both to nitric oxide measurement and sinus or nasal problems. A title search was carried out on these manuscripts to select those relevant to clinical or basic science aspects of nitric oxide measurement. A subsequent abstract search selected those manuscripts concerning the application of nitric oxide measurement to sinonasal problems. The manuscripts selected were subject to a full-text review to extract data sets of nasal nitric oxide readings for different patient groups. RESULTS: Initially, 1088 manuscripts were selected. A title search found 335 manuscripts of basic scientific or clinical interest. An abstract search found 35 manuscripts directly relating to nitric oxide measurement in sinonasal disease. Full-text analysis produced 20 studies with extractable data on nasal nitric oxide levels in clearly defined patient groups. Studies did not show sufficient homogeneity to enable substantial meta-analysis of aggregated data. CONCLUSION: Current evidence shows that nasal nitric oxide is not a clinically useful measure for sinonasal disease. Although there is some evidence that sinus surgery is associated with lowered nasal nitric oxide levels, there is no evidence that this is associated with deterioration in sinus health.


Asunto(s)
Mucosa Nasal/química , Óxido Nítrico/análisis , Enfermedades Nasales/metabolismo , Enfermedades de los Senos Paranasales/metabolismo , Senos Paranasales/química , Humanos , Enfermedades Nasales/diagnóstico , Enfermedades de los Senos Paranasales/diagnóstico
15.
J Chromatogr B Analyt Technol Biomed Life Sci ; 877(22): 2011-8, 2009 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-19553163

RESUMEN

Volatile compounds from human breath are a potential source of information for disease diagnosis. Breath may include volatile organic compounds (VOCs) originating in the nasal sinuses. If the sinuses are infected, disease-specific volatiles may enter exhaled air. Sinus infections are commonly caused by several known bacteria. We examined the volatiles characteristic of infectious bacteria in culture using solid-phase microextraction to collect and gas chromatography-mass spectrometry as well as gas chromatography with flame photometric detection to separate and analyze the resulting VOCs. Infected sinus mucus samples were also collected and their VOCs examined. Similar characteristic volatiles were seen from both cultures of individual "pure" bacteria and several mucus samples. However, the relative amounts of characteristic VOCs from individual bacteria differ greatly between cultures and sinus mucus. New compounds, not seen in culture were also seen in some mucus samples. Our results suggest an important role for growth substrate and environment. Our data further suggests that in some sinus mucus samples identification of bacteria-specific volatiles is possible and can suggest the identity of an infecting organism to physicians. Knowledge of these bacteria-related volatiles is necessary to create electronic nose-based, volatile-specific sensors for non-invasive examination for suspected sinus infection.


Asunto(s)
Bacterias/química , Infecciones Bacterianas/microbiología , Cromatografía de Gases y Espectrometría de Masas/métodos , Moco/microbiología , Senos Paranasales/microbiología , Microextracción en Fase Sólida/métodos , Compuestos Orgánicos Volátiles/análisis , Bacterias/metabolismo , Humanos , Moco/química , Senos Paranasales/química , Compuestos Orgánicos Volátiles/metabolismo
16.
Hum Pathol ; 40(3): 283-92, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19150107

RESUMEN

Primary poorly differentiated (small round and non-small) sinonasal neoplasms comprise histogenetically and biologically diverse entities with overlapping morphologic features. Because of the limited initial biopsy tissue materials, differential diagnostic difficulties may arise and complicate timely management of some cases. We used immunohistochemical and molecular marker analyses in a large cohort of these tumors to optimize their early diagnosis and classification. Fifty-two tumors of the skull base and sinonasal regions and, for comparison, 19 poorly differentiated neoplasms of other head and neck sites were analyzed by a panel of immunohistochemical markers including those of epithelial, mesenchymal, melanocytic, and neuroectodermal origin using tissue microarray. Reverse transcriptase-polymerase chain reaction analysis of messenger RNA for EWS-FLI1 and PAX-FKHR fusion transcripts and the human achaete-scute homolog-1 gene was performed on 24 of the 52 sinonasal tumors and the 19 tumors of other sites for comparison. The immunohistochemical results substantiated the phenotypic assessment and the initial diagnosis in 49 of the 52 tumors. In 4 instances the integrated markers and phenotypic analyses led to reclassification of 3 tumors and confirmed the histogenesis of a mesenchymal tumor with aberrant cytokeratin expression. Molecular analysis of the EWS-FLI1 fusion gene transcript revealed 4 (9.3%) of the 43 tumors to be positive; all were Ewing sarcomas. The human achaete-scute homolog-1 gene transcript was identified in 10 (23.8%) of 42 tumors: 3 of 6 neuroblastomas, all 4 neuroendocrine carcinomas, and 1 each in sinonasal undifferentiated carcinoma, rhabdomyosarcoma, and melanoma. The PAX-FKHR fusion transcript was not detected in any tumors. We conclude that (1) an integrated morphologic and biomarker algorithm may better optimize the early diagnosis of poorly differentiated sinonasal and skull-base tumors; (2) molecular analysis may assist in future biological stratification of certain classes of these tumors; and (3) the human achaete-scute homolog-1 gene transcript is a nonspecific marker for the diagnosis of neuroblastoma.


Asunto(s)
Carcinoma Neuroendocrino/diagnóstico , Melanoma/diagnóstico , Neoplasias de los Senos Paranasales/diagnóstico , Senos Paranasales/patología , Rabdomiosarcoma/diagnóstico , Neoplasias de la Base del Cráneo/diagnóstico , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/genética , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/genética , Carcinoma Neuroendocrino/química , Carcinoma Neuroendocrino/genética , ADN de Neoplasias/análisis , Detección Precoz del Cáncer , Perfilación de la Expresión Génica , Humanos , Inmunofenotipificación , Melanoma/química , Melanoma/genética , Técnicas de Diagnóstico Molecular/métodos , Proteínas de Fusión Oncogénica/genética , Neoplasias de los Senos Paranasales/química , Neoplasias de los Senos Paranasales/genética , Senos Paranasales/química , Proteína Proto-Oncogénica c-fli-1/genética , ARN Neoplásico/análisis , Proteína EWS de Unión a ARN , Rabdomiosarcoma/química , Rabdomiosarcoma/genética , Neoplasias de la Base del Cráneo/química , Neoplasias de la Base del Cráneo/genética , Análisis de Matrices Tisulares
17.
Eur J Clin Invest ; 39(1): 72-7, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19087132

RESUMEN

BACKGROUND: Specific guidelines are developed for the measurement of bronchial FE(NO), however, nasal nitric oxide (nNO) measurement is not standardised yet, resulting in divergent nNO values. This study compares six different sampling methods for nNO as described in the literature, to analyse their outcome and short term and long term reproducibility. DESIGN: nNO concentrations were measured in 38 healthy subjects. Each subject performed nNO measurements during tidal breathing (nNO-TB), single breath quiet exhalations (nNO-QE), QE with oral exhalation against a resistance (nNO-QE + R), breath holding (nNO-BH) and during single-breath humming exhalations at 128 and 440 Hz (nNO-HE(128) and nNO-HE(440), respectively). To assess short term and long term reproducibility all manoeuvres were repeated after one and 24 h. RESULTS: Lowest values were found during quiet exhalation (mean nNO-QE was 364 p.p.b., SEM 27). Methods in which there is turbulence of nasal flow (as in TB, HE(128) and HE(440)) result in higher nNO levels. Highest values were found in methods with decreased nasal flow [when there is no nasal flow as in BH or when the velum is closed as in QE + R: mean nNO 763 p.p.b. (SEM 61)]. NNO during humming at 440 Hz was significantly higher than at 128 Hz (P < 0.01). The within-subject coefficient of variation of repeated measurements was lowest during humming and breath holding, 3.4 and 3.8%, respectively. Concerning short term and long term reproducibility, best agreement is reached with humming and second best with breath holding. CONCLUSIONS: Different methods result in different levels and reproducibility of nNO. In regard to this, methods of humming and breath holding are recommended for standardised measurement of nasal NO.


Asunto(s)
Cavidad Nasal/química , Óxido Nítrico/análisis , Senos Paranasales/química , Adolescente , Adulto , Pruebas Respiratorias/métodos , Femenino , Humanos , Masculino , Reproducibilidad de los Resultados , Adulto Joven
18.
Am J Rhinol ; 20(4): 461-5, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16955780

RESUMEN

BACKGROUND: Surfactant-associated proteins (SP) A and D are in the family of collectin proteins that play an integral part in the innate defense system. SP-A and SP-D expression and function are altered in a variety of inflammatory and infectious diseases of the lungs, such as asthma, allergies, and cystic fibrosis. Our prior studies are the first to identify the presence of these proteins in the human sinonasal cavity. The objective of this study was to immunolocalize SP-A and SP-D in human sinonasal tissue. METHODS: Sinonasal mucosal biopsies were performed in patients with various forms of chronic hyperplastic rhinosinusitis with nasal polyposis and nondiseased mucosa from patients undergoing transsphenoidal hypophysectomy. (n = 10) Immunolocalization of surfactant proteins was performed with antibodies to SP-A and SP-D using immunoperoxidase staining technique. Isotype-negative controls were performed on all specimens. RESULTS: Analyses of mucosal biopsy specimens from human sinonasal tissue reveals staining within respiratory and intermediate (metaplastic)-type surface epithelium. In addition, staining was intense in the submucosal ductal epithelium of the seromucinous glands. These properties appear to be consistent regardless of disease state and location within the sinuses. CONCLUSION: This is the first study to immunolocalize SP-A and SP-D in sinonasal human mucosa. These are secreted proteins that are intricately involved in innate immunity in the lungs. Their secretion in the upper airway indicates that future studies may allow manipulation of these proteins and development of novel treatments for sinonasal pathology.


Asunto(s)
Mucosa Nasal/química , Senos Paranasales/química , Proteína A Asociada a Surfactante Pulmonar/análisis , Proteína D Asociada a Surfactante Pulmonar/análisis , Mucosa Respiratoria/química , Humanos , Inmunohistoquímica , Mucosa Nasal/inmunología , Mucosa Nasal/patología , Senos Paranasales/inmunología , Senos Paranasales/patología , Proteína A Asociada a Surfactante Pulmonar/inmunología , Proteína D Asociada a Surfactante Pulmonar/inmunología , Mucosa Respiratoria/inmunología , Mucosa Respiratoria/patología , Rinitis/inmunología , Rinitis/patología , Sinusitis/inmunología , Sinusitis/patología
19.
Laryngoscope ; 116(2): 328-30, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16467728

RESUMEN

OBJECTIVES: Surfactant protein A (SP-A) is protein that appears to play an important role in mammalian first-line host defense. However, the presence of SP-A in the human paranasal sinus mucosa is not well known. The purpose of this study was to investigate the expression of SP-A protein in human paranasal sinus mucosa and to compare the expression of SP-A mRNA between normal paranasal sinus mucosa and paranasal sinus mucosa with chronic rhinosinusitis. METHODS: Paranasal sinus mucosa samples from 10 patients who underwent surgery for chronic rhinosinusitis without polyps and 10 normal control subjects were used. Reverse transcriptase polymerase chain reaction was done to detect SP-A mRNA. The expression level of SP-A transcripts was semiquantified with desitometry. Cellular localization of SP-A was sought by using immunohistochemistry. RESULTS: SP-A mRNA and protein were expressed in the human paranasal sinus mucosa. SP-A/GAPDH mRNA ratio in the paranasal sinus mucosa with chronic rhinosinusitis was greater compared with that in normal paranasal sinus mucosa (P<.05). Immunohistochemical staining revealed SP-A immunoreactivity in the epithelial cells and submucosal glands of paranasal sinus mucosa in both control subjects and chronic sinusitis patients. Stronger immunoreactivity was observed in chronic rhinosinusitis mucosa as compared with normal paranasal sinus mucosa. CONCLUSION: SP-A mRNA and protein are present in both normal and diseased human paranasal sinus mucosa. These results may provide potential targets for novel therapy of chronic rhinosinusitis.


Asunto(s)
Senos Paranasales/química , Proteína A Asociada a Surfactante Pulmonar/biosíntesis , Rinitis/metabolismo , Sinusitis/metabolismo , Adulto , Enfermedad Crónica , Femenino , Humanos , Masculino , Mucosa Nasal/química , Procedimientos Quirúrgicos Otorrinolaringológicos , Proteína A Asociada a Surfactante Pulmonar/análisis , Rinitis/cirugía , Sinusitis/cirugía , Regulación hacia Arriba
20.
Otolaryngol Head Neck Surg ; 132(5): 713-6, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15886623

RESUMEN

OBJECTIVE: The purpose of this study was to examine the changes in nitric oxide (NO) level in the nasal and paranasal sinus mucosa after exposure radiofrequency electromagnetic fields (EMF). STUDY DESIGN AND SETTING: Thirty male Sprague-Dawley rats were randomly grouped as follows: EMF group (group I; n, 10), EMF group in which melatonin received (group II; n, 10) and the control (sham operated) group (group III; n, 10). Groups I and II were exposed to a 900 MHz. Oral melatonin was given in group II. Control rats (group III) were also placed in the tube as the exposure groups, but without exposure to EMF. At the end of 2 weeks, the rats were sacrificed, and the nasal and paranasal sinus mucosa dissected. NO was measured in nasal and paranasal mucosa. RESULTS: The nasal and paranasal sinus mucosa NO levels of group I were significantly higher than those of the control group (group III) ( P < 0.05). However, there was no statistically significant difference between group II and the control group (group III) regarding NO output ( P > 0.05). CONCLUSION: Exposure to EMF released by mobile phones (900 MHz) increase NO levels in the sinus and nasal mucosa. SIGNIFICANCE: Increased NO levels may act as a defense mechanism and presumably related to tissue damage. In addition, melatonin may have beneficial effect to prevent these changes in the mucosa.


Asunto(s)
Teléfono Celular , Campos Electromagnéticos , Mucosa Nasal/química , Óxido Nítrico/análisis , Senos Paranasales/química , Animales , Masculino , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...